查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466749

臨床微生物學市場：按產品類型、檢體類型、最終用戶、應用分類 - 全球預測 2024-2030

Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年臨床微生物學市場規模為78億美元，預計2024年將達86.8億美元，2030年將達到161.2億美元，複合年成長率為10.91%。

臨床微生物學涵蓋廣泛的實驗室方法，並且在生物體以及用於分離和鑑定它們的方法方面很複雜。臨床微生物學重點研究引起感染疾病的微生物，分離和鑑定細菌、病毒、寄生蟲和真菌等傳染性生物體，以及管理和治療患者。感染疾病率的增加、疾病預防意識的增強以及醫療保健成本的上升正在推動臨床微生物學的使用。臨床微生物實驗室品質保證和管理方面的挑戰，加上設備和基礎設施的有限性，可能會阻礙產品滲透到市場。此外，臨床微生物學設備和製程的技術進步為醫學檢測企業擴大其產品組合和提高盈利提供了各種機會。

主要市場統計
基準年[2023] 78億美元
預測年份 [2024] 86.8億美元
預測年份 [2030] 161.2億美元
複合年成長率（%） 10.91%

實驗室設備在產品臨床微生物學評估中的使用

培養箱、生物安全櫃、離心機、顯微鏡等實驗室設備在臨床微生物學評估中有著廣泛的應用。臨床微生物學家更喜歡專門的試劑和分析設備來培養、檢測、可視化和識別微生物，如細菌、古細菌、病毒、真菌和原生動物。臨床試劑和分析儀有助於研究微生物的型態、結構、分類、遺傳變異、生理和生化，以進行快速臨床診斷。

檢體類型 血清樣本是血清學檢體的首選，以檢測過去或目前的感染疾病。

血液檢體對於檢測引起敗血症、心內膜炎和其他全身性感染疾病的血源性病原體至關重要。胸腔積水、腹水和心包膜液等體液對於漿膜腔感染疾病的診斷至關重要。腦脊髓液檢體對於診斷腦膜炎和腦炎等中樞神經系統感染疾病至關重要。糞便檢體對於診斷胃腸道感染疾病和監測腸道病原體的抗菌藥物抗藥性至關重要。唾液檢體最近作為診斷呼吸道感染疾病（包括 COVID-19）的傳統方法的非侵入性替代方法而受到關注。血清檢體對於透過測量病原體特異性抗體來檢測過去或目前感染疾病的血清學測試至關重要。

最終使用者：實驗室和研究機構採用臨床微生物學可以詳細了解感染疾病狀況。

臨床微生物學評估是在臨床實驗室、醫院/醫療機構、學術/研究機構中進行的，以分離和表徵感染性微生物，以有效診斷疾病狀態。實驗室和研究機構利用臨床微生物學技術為醫療保健專業人員提供對感染疾病的詳細了解。

應用 透過識別致病病原體，更多地使用臨床微生物學來診斷胃腸道 (GI) 疾病

自體免疫疾病，包括類風濕性關節炎和狼瘡，是免疫系統攻擊健康細胞的疾病。臨床微生物學透過識別特定的自身抗體和發炎標記物來幫助診斷這些疾病。臨床微生物學的心臟科應用包括診斷影響心血管系統的感染疾病，例如心內膜炎和心肌炎。快速識別病原體可以實現標靶治療並改善結果。臨床微生物學透過識別可能影響血糖控制或引起併發症的感染疾病（例如由金黃色葡萄球菌等細菌引起的尿道感染和足部潰瘍）在糖尿病管理中發揮作用。在藥物測試中，臨床微生物學監測抗菌素抗藥性模式並確保在感染疾病治療中選擇適當的治療方法。臨床微生物學透過識別幽門螺旋桿菌和艱難梭菌等致病病原體，有助於胃腸道 (GI) 疾病的診斷。腎臟科特異性微生物檢測可診斷腎臟相關感染疾病，例如腎盂腎炎，需要特定的抗生素治療。臨床微生物學中的腫瘤學應用可診斷癌症相關感染疾病，這些感染可能會影響治療計劃或導致併發症。在牙周病中，臨床微生物學幫助牙醫識別口腔中引起牙齦炎和牙周炎等疾病的病原體，使他們能夠選擇適當的治療方法。

區域洞察

在北美，主導市場參與者的存在、研發投資的增加以及感染疾病的流行正在顯著推動臨床微生物學的採用。在美國，製藥和醫療保健領域高度發達，刺激了先進臨床診斷技術的採用。開拓靶向聚合酵素鏈鎖反應(PCR) 等新型創新微生物技術，以提高成本效益並改善臨床結果，正在加強該地區臨床微生物學市場的成長。在亞太地區，廣譜診斷和分子診斷越來越受歡迎，以提高診斷靈敏度和時間效率，為臨床微生物學的發展做出了重大貢獻。蓬勃發展的醫療旅遊業預計將推動印度、中國、泰國和馬來西亞等亞洲國家對微生物診斷和監測測試的需求。在歐洲地區，致病性疾病數量的不斷增加、適應性細菌的不斷發現以及對快速微生物檢測方法的需求不斷成長正在推動臨床微生物學技術的使用。

FPNV定位矩陣

FPNV定位矩陣對於評估臨床微生物學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對臨床微生物學市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 臨床微生物學市場的市場規模與預測是多少？

2.在臨床微生物學市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3. 臨床微生物學市場的技術趨勢和法規結構是什麼？

4.臨床微生物市場主要廠商的市場佔有率為何？

5. 進入臨床微生物市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加臨床微生物學在感染疾病管理與控制的應用
      • 政府和私人組織對癌症診斷和研究的積極支持和努力
    • 抑制因素
      • 缺乏熟練的專業人員、設備和基礎設施
    • 機會
      • 臨床微生物學產品和製程的技術進步
      • 照護現場微生物檢測簡介
    • 任務
      • 臨床微生物實驗室的品質保證與控制問題
  • 市場區隔分析
    • 產品：實驗室設備在臨床微生物學評估中的使用
    • 檢體類型：首選血清樣本進行血清學檢測，以檢測過去或目前的感染情況
    • 最終用戶：在實驗室和研究中應用臨床微生物學，提供有關感染疾病病理學的詳細資訊
    • 應用：識別致病病原體增加了臨床微生物學在胃腸道疾病診斷的應用
  • 市場趨勢分析
    • 不斷開發先進臨床微生物學測試的成熟市場供應商的存在
    • 亞太地區感染疾病流行與臨床微生物學產品的改進
    • 政府的支持努力和正在進行的研究，以克服歐洲、中東和非洲地區的感染疾病負擔
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章臨床微生物學市場：依產品

  • 裝置
  • 試劑

第7章臨床微生物學市場樣本類型

  • 血
  • 體液
  • 腦脊髓液
  • 屎
  • 唾液
  • 血清
  • 滑液
  • 尿

第8章臨床微生物學市場：依最終使用者分類

  • 學術研究所
  • 醫院和護理提供者
  • 研究機構

第9章臨床微生物學市場：依應用分類

  • 自體免疫疾病
  • 心臟病學
  • 糖尿病
  • 藥檢
  • 消化系統疾病
  • 腎臟病學
  • 腫瘤學
  • 牙周疾病
  • 呼吸系統疾病
  • 性行為感染傳染病

第10章美洲臨床微生物學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太臨床微生物學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲臨床微生物學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 威奇托州立大學 MDL 實驗室轉向微生物學。
    • 劍橋Start-Ups贏得了開發新診斷技術的資金。
    • 微生物學會與印度班加羅爾科學研究所簽署轉型協議
    • Hardy Diagnostics 與 Premier 簽署手冊微生物學協議
    • 醫學微生物學系推出了四個總價值 680 萬美元的新計劃和一個新網站。
    • ASM 資助包容性微生物學領導計畫。
    • MAESTRIA 是 Biomerieux 開發的新一代微生物學中間件，可最佳化實驗室工作流程並改善患者照護。
    • Beckman Coulter 和 MeMed 將擴大經過驗證的宿主免疫反應診斷的使用範圍，這些診斷可以區分病毒和細菌感染。
    • BD 為微生物實驗室安裝全自動機器人軌道系統。
    • FASTinov 與 Beckman Coulter Life Sciences 合作，將超快 2h-AST 創新技術引入臨床微生物實驗室。
    • 北部計劃開設一個萊姆病和蜱傳疾病的多學科治療中心。
    • Bio-Rad 擴大了 Abbott 診斷平台的品質控制覆蓋範圍。
    • 聯邦資金將增強亞伯達大學應對高傳染性病原體的能力。
    • 牛津大學獲得 1.22 億英鎊（1.3663 億美元）的醫療保健研究資金。
    • Sci-Tech Daresbury 旗下的 Perfectus Biomed Group 已被醫療設備測試領域的全球領導者 NAMSA 收購。
    • HORIBA Veterinary 為難以診斷的寄生蟲增加了新的快速 PCR 檢測。
    • ValitaCell 加入貝克曼庫爾特生命科學公司。
    • Global Access Diagnostics 從 Bio-Rad Laboratories 獲得了 IT-LEISH 快速診斷測試的製造權。
    • SSI Diagnostica 持續強勁成長。
    • BD 和 Accelerate Diagnostics 宣佈建立全球商業合作夥伴關係。
    • SGS 在亞利桑那州鳳凰城開設了一個新的微生物實驗室。
    • 以色列：歐盟向以色列微生物診斷公司 Pocared 提供 2,200 萬歐元（2,426 萬美元）。
    • DCN Dx 收購微生物檢測產品公司 Biomed Diagnostics。
    • 生物梅里埃透過收購 Specific Diagnostics （創新企業），加強了對抗抗菌素抗藥性的努力。
    • 美國國立衛生研究院 (NIH) 資助新的結核病研究和發展中心。
    • Raue 為 Sonic Healthcare 收購 Diagnosticum Laboratory Group 提供顧問服務。
    • ATCC 宣布與 QIAGEN 建立合作夥伴關係，以擴展其生物資訊資料平台。
    • Hardy Diagnostics 現在提供 BioCode MDx-3000。
    • 默克宣布對其生命科學業務部門進行組織變革，以加強其 CDMO 產品並加速未來成長。
    • COPAN Diagnostics 宣布臨床微生物學人工智慧發展又邁出了重要一步。

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4312A385A416

[189 Pages Report] The Clinical Microbiology Market size was estimated at USD 7.80 billion in 2023 and expected to reach USD 8.68 billion in 2024, at a CAGR 10.91% to reach USD 16.12 billion by 2030.

Clinical microbiology encompasses a wide range of testing methods, and it is complex in terms of organisms and methods used to isolate & identify them. Clinical microbiology investigates microorganisms that cause infectious diseases and focuses on isolating and characterizing infectious organisms such as bacteria, viruses, parasites, and fungi to manage and treat patients. The increasing occurence of infectious diseases, growing awareness of disease prevention, and increasing healthcare expenditure are all factors driving the use of clinical microbiology. Problems concerning quality assurance and management in clinical microbiology laboratories coupled with limited availability of equipment and infrastructure can pose a challenge to product penetration in the market. Additionally, technological advancement in clinical microbiology instruments and processes presents various opportunities for medical laboratory businesses to expand their portfolio and increase profitability.

KEY MARKET STATISTICS
Base Year [2023] USD 7.80 billion
Estimated Year [2024] USD 8.68 billion
Forecast Year [2030] USD 16.12 billion
CAGR (%) 10.91%

Product: Use of laboratory instruments in clinical microbiology assessments

Laboratory instruments such as incubators, biosafety cabinets, centrifuges, and microscopes include a wide scope of applications in clinical microbiology assessments. Clinical microbiologists prefer specialized reagents & analyzers to culture, detect, visualize, and identify microscopic organisms such as bacteria, archaea, viruses, fungi, or protozoa. Clinical reagents & analyzers aid in studying the morphology, structure, classification, genetic variation, physiology, and biochemistry of microorganisms for rapid clinical diagnostics.

Specimen Type: Preference for serum samples in serological testing to detect past or current infections

Blood specimens are essential for detecting bloodborne pathogens responsible for sepsis, endocarditis, and other systemic infections. Body fluids such as pleural, peritoneal, or pericardial fluid are crucial for diagnosing infections in serous cavities. CSF specimens are critical in diagnosing central nervous system infections, including meningitis or encephalitis. Fecal specimens are crucial for diagnosing gastrointestinal infections and monitoring antimicrobial resistance in enteric pathogens. Saliva specimens have gained attention in recent years as non-invasive alternatives to traditional methods for diagnosing respiratory infections, including COVID-19. Serum samples are essential for serological testing to detect past or current infections by measuring pathogen-specific antibodies.

End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions

Clinical microbiology assessments are performed at clinical laboratories, hospitals & care providers, and academic & research institutes to isolate and characterize infectious organisms for diagnosing disease conditions effectively. Laboratories and research institutes provide detailed insights regarding infectious disease conditions to healthcare professionals using clinical microbiology techniques.

Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens

Autoimmune diseases, including rheumatoid arthritis and lupus, involve the immune system attacking healthy cells. Clinical microbiology helps diagnose these conditions by identifying specific autoantibodies or inflammatory markers. Cardiology applications in clinical microbiology include diagnosing infections that affect the cardiovascular system, such as endocarditis and myocarditis. Rapid identification of pathogens enables targeted treatment and improved outcomes. Clinical microbiology plays a role in diabetes management by identifying infections that may impact blood glucose control or cause complications, such as urinary tract infections or foot ulcers infected by bacteria such as Staphylococcus aureus. In drug testing, clinical microbiology monitors antimicrobial resistance patterns to ensure appropriate therapeutic choices for infectious disease treatment. Clinical microbiology contributes to diagnosing gastrointestinal (GI) diseases by identifying causative pathogens, such as Helicobacter pylori or Clostridioides difficile. Nephrology-focused microbiology tests diagnose kidney-related infections, such as pyelonephritis, which requires specific antimicrobial therapies. Oncology applications within clinical microbiology involve diagnosing cancer-related infections that can compromise treatment plans or contribute to complications. In periodontal diseases, clinical microbiology helps dentists identify oral pathogens responsible for conditions such as gingivitis and periodontitis, enabling appropriate treatment selection.

Regional Insights

In North America, the strong presence of leading market players, increasing investments in research & development, and the growing prevalence of infectious diseases significantly increase the adoption of clinical microbiology. Highly developed pharmaceutical and healthcare sectors in the United States are fueling the adoption of advanced clinical diagnostic techniques. Developing new and innovative microbiological technologies, such as targeted polymerase chain reactions (PCRs), to increase cost-effectiveness and improve clinical outcomes is strengthening the market growth of clinical microbiology across the region. In Asia-Pacific, the growing popularity of broad-range and molecular diagnosis to surge the sensitivity of diagnosis while promoting time effectiveness significantly contributes to the development of clinical microbiology. The booming medical tourism industry is expected to increase the need for microbial diagnostic and monitoring tests in Asian countries such as India, China, Thailand, and Malaysia. In the Europe region, the increasing prevalence of pathogenic diseases, growth in the discovery of adapting bacterium, and the rising need for speedy microbiological testing methods enhance the utilization of clinical microbiology technology.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Microbiology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Microbiology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Instruments, LLC, Agilent Technologies, Inc., B. Braun SE, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Cardinal Health, Inc., Clinichem Ltd., COPAN Diagnostics Inc., Diagnostica Longwood S.L., ELITech Group, F. Hoffmann-La Roche Ltd., Hardy Diagnostics, HORIBA, Ltd., Kyokuto Pharmaceutical Industrial Co., Ltd., Laboratorios Conda, S.A., Liofilchem S.r.l., Merck KGaA, Prestige Diagnostics U.K. Ltd., Pro Lab Diagnostics Inc., QIAGEN N.V., Rapid Micro Biosystems, Inc., Shimadzu Corporation, SSI Diagnostica A/S, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Vircell S.L..

Market Segmentation & Coverage

This research report categorizes the Clinical Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents
  • Specimen Type
    • Blood
    • Body fluids
    • Cerebrospinal Spinal Fluid
    • Fecal
    • Saliva
    • Serum
    • Synovial Fluid
    • Urine
  • End-User
    • Academic & Research Institutes
    • Hospitals & Care Providers
    • Laboratories
  • Application
    • Autoimmune Diseases
    • Cardiology
    • Diabetes
    • Drug Testing
    • Gastrointestinal Diseases
    • Nephrology
    • Oncology
    • Periodontal Diseases
    • Respiratory Diseases
    • Sexually Transmitted Diseases
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Microbiology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Microbiology Market?

3. What are the technology trends and regulatory frameworks in the Clinical Microbiology Market?

4. What is the market share of the leading vendors in the Clinical Microbiology Market?

5. Which modes and strategic moves are suitable for entering the Clinical Microbiology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of clinical microbiology in managing and controlling infectious diseases
      • 5.1.1.2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals, equipment and infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in clinical microbiology products and processes
      • 5.1.3.2. Introduction of point-of-care microbiology testing
    • 5.1.4. Challenges
      • 5.1.4.1. Problems concerning quality assurance and management in clinical microbiology laboratories
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Use of laboratory instruments in clinical microbiology assessments
    • 5.2.2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
    • 5.2.3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
    • 5.2.4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
  • 5.3. Market Trend Analysis
    • 5.3.1. Presence of well-established market vendors with the ongoing development of advanced clinical microbiology testings
    • 5.3.2. Prevalence of infectious disease and improvements in clinical microbiology products in APAC
    • 5.3.3. Supportive government initiatives and ongoing research to overcome the burden of infectious diseases in the EMEA region
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Clinical Microbiology Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents

7. Clinical Microbiology Market, by Specimen Type

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Body fluids
  • 7.4. Cerebrospinal Spinal Fluid
  • 7.5. Fecal
  • 7.6. Saliva
  • 7.7. Serum
  • 7.8. Synovial Fluid
  • 7.9. Urine

8. Clinical Microbiology Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Hospitals & Care Providers
  • 8.4. Laboratories

9. Clinical Microbiology Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
  • 9.3. Cardiology
  • 9.4. Diabetes
  • 9.5. Drug Testing
  • 9.6. Gastrointestinal Diseases
  • 9.7. Nephrology
  • 9.8. Oncology
  • 9.9. Periodontal Diseases
  • 9.10. Respiratory Diseases
  • 9.11. Sexually Transmitted Diseases

10. Americas Clinical Microbiology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Microbiology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Microbiology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Wichita State's MDL Lab Shifting To Microbiology.
    • 13.3.2. Cambridge Start-Up Won Funding To Develop New Diagnostics.
    • 13.3.3. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
    • 13.3.4. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
    • 13.3.5. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
    • 13.3.6. ASM Funded for Inclusive Microbiology Leaders Program.
    • 13.3.7. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomerieux to Optimize Laboratory Workflow and Improve Patient Care.
    • 13.3.8. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
    • 13.3.9. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
    • 13.3.10. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
    • 13.3.11. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
    • 13.3.12. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
    • 13.3.13. Federal Funds Set To Boost U of A's Ability To Handle Highly Infectious Pathogens.
    • 13.3.14. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
    • 13.3.15. Sci-Tech Daresbury's Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
    • 13.3.16. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
    • 13.3.17. ValitaCell Joins Beckman Coulter Life Sciences.
    • 13.3.18. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
    • 13.3.19. SSI Diagnostica Continues a Strong Growth Journey.
    • 13.3.20. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
    • 13.3.21. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
    • 13.3.22. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
    • 13.3.23. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
    • 13.3.24. bioMerieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
    • 13.3.25. NIH Funded New Tuberculosis Research Advancement Centers.
    • 13.3.26. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
    • 13.3.27. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
    • 13.3.28. Hardy Diagnostics Now Offers the BioCode MDx-3000.
    • 13.3.29. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
    • 13.3.30. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL MICROBIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 229. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 311. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 314. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 315. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 324. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 325. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 330. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 331. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 342. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 343. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. SOUTH AFRICA CLINICAL MICROBIOLOGY